

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.20929583 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.00074482 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.83096152 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.77551718 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.77551718 |
| 6 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.45362590 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.18849917 |
| 8 | mannose metabolic process (GO:0006013) | 4.07996143 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 4.06927513 |
| 10 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.06927513 |
| 11 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.06188010 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.99528371 |
| 13 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.85030868 |
| 14 | regulation of cholesterol homeostasis (GO:2000188) | 3.83429702 |
| 15 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.79003507 |
| 16 | L-phenylalanine metabolic process (GO:0006558) | 3.79003507 |
| 17 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.66465639 |
| 18 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.66465639 |
| 19 | modulation by symbiont of host immune response (GO:0052553) | 3.66465639 |
| 20 | positive regulation by symbiont of host defense response (GO:0052509) | 3.66465639 |
| 21 | modulation by symbiont of host defense response (GO:0052031) | 3.66465639 |
| 22 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.66465639 |
| 23 | alpha-linolenic acid metabolic process (GO:0036109) | 3.64907850 |
| 24 | drug catabolic process (GO:0042737) | 3.63808056 |
| 25 | urea cycle (GO:0000050) | 3.62215852 |
| 26 | urea metabolic process (GO:0019627) | 3.62215852 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 3.50565796 |
| 28 | synaptic vesicle maturation (GO:0016188) | 3.50227059 |
| 29 | locomotory exploration behavior (GO:0035641) | 3.46664887 |
| 30 | aromatic amino acid family catabolic process (GO:0009074) | 3.44481939 |
| 31 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.44445626 |
| 32 | detection of bacterium (GO:0016045) | 3.44034896 |
| 33 | detection of other organism (GO:0098543) | 3.43142682 |
| 34 | glutamate metabolic process (GO:0006536) | 3.40776882 |
| 35 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.40753755 |
| 36 | gamma-aminobutyric acid transport (GO:0015812) | 3.35013632 |
| 37 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.34265689 |
| 38 | intestinal cholesterol absorption (GO:0030299) | 3.31237427 |
| 39 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.30868344 |
| 40 | phospholipid efflux (GO:0033700) | 3.30323695 |
| 41 | leukocyte aggregation (GO:0070486) | 3.30304561 |
| 42 | high-density lipoprotein particle remodeling (GO:0034375) | 3.30269201 |
| 43 | sodium ion export (GO:0071436) | 3.29230253 |
| 44 | nitrogen cycle metabolic process (GO:0071941) | 3.27895091 |
| 45 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.26490218 |
| 46 | negative regulation of sterol transport (GO:0032372) | 3.26399832 |
| 47 | negative regulation of cholesterol transport (GO:0032375) | 3.26399832 |
| 48 | bile acid biosynthetic process (GO:0006699) | 3.23913105 |
| 49 | neutrophil activation involved in immune response (GO:0002283) | 3.21208796 |
| 50 | kynurenine metabolic process (GO:0070189) | 3.17421586 |
| 51 | alanine transport (GO:0032328) | 3.16278516 |
| 52 | positive thymic T cell selection (GO:0045059) | 3.15230109 |
| 53 | response to peptidoglycan (GO:0032494) | 3.14405692 |
| 54 | regulation of ARF protein signal transduction (GO:0032012) | 3.11831594 |
| 55 | phospholipid homeostasis (GO:0055091) | 3.09696231 |
| 56 | exogenous drug catabolic process (GO:0042738) | 3.09491702 |
| 57 | thymic T cell selection (GO:0045061) | 3.09415337 |
| 58 | reverse cholesterol transport (GO:0043691) | 3.05658666 |
| 59 | cysteine metabolic process (GO:0006534) | 3.05512358 |
| 60 | response to muramyl dipeptide (GO:0032495) | 3.05469985 |
| 61 | homocysteine metabolic process (GO:0050667) | 3.05166306 |
| 62 | lysine metabolic process (GO:0006553) | 3.04960257 |
| 63 | lysine catabolic process (GO:0006554) | 3.04960257 |
| 64 | regulation of ARF GTPase activity (GO:0032312) | 3.04385213 |
| 65 | signal complex assembly (GO:0007172) | 3.02043115 |
| 66 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.01365750 |
| 67 | macroautophagy (GO:0016236) | 3.00402677 |
| 68 | regulation of gamma-delta T cell activation (GO:0046643) | 3.00155589 |
| 69 | indole-containing compound catabolic process (GO:0042436) | 3.00009191 |
| 70 | indolalkylamine catabolic process (GO:0046218) | 3.00009191 |
| 71 | tryptophan catabolic process (GO:0006569) | 3.00009191 |
| 72 | regulation of leukocyte degranulation (GO:0043300) | 2.97880046 |
| 73 | cholesterol efflux (GO:0033344) | 2.97818224 |
| 74 | cellular potassium ion homeostasis (GO:0030007) | 2.96442623 |
| 75 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.96003958 |
| 76 | neurotransmitter secretion (GO:0007269) | 2.94811754 |
| 77 | bile acid metabolic process (GO:0008206) | 2.94527373 |
| 78 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.94286933 |
| 79 | regulation of bile acid biosynthetic process (GO:0070857) | 2.94059779 |
| 80 | proline transport (GO:0015824) | 2.93960099 |
| 81 | intestinal absorption (GO:0050892) | 2.91155355 |
| 82 | regulation of extracellular matrix disassembly (GO:0010715) | 2.90874000 |
| 83 | regulation of triglyceride catabolic process (GO:0010896) | 2.88735139 |
| 84 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.88731160 |
| 85 | cellular modified amino acid catabolic process (GO:0042219) | 2.87512556 |
| 86 | NIK/NF-kappaB signaling (GO:0038061) | 2.87258338 |
| 87 | protein carboxylation (GO:0018214) | 2.87056593 |
| 88 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.87056593 |
| 89 | response to laminar fluid shear stress (GO:0034616) | 2.86638113 |
| 90 | sulfur amino acid catabolic process (GO:0000098) | 2.86513134 |
| 91 | regulation of cholesterol esterification (GO:0010872) | 2.86139166 |
| 92 | tryptophan metabolic process (GO:0006568) | 2.85598366 |
| 93 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.83839889 |
| 94 | negative regulation of fibrinolysis (GO:0051918) | 2.83024969 |
| 95 | T cell selection (GO:0045058) | 2.82893836 |
| 96 | plasma lipoprotein particle assembly (GO:0034377) | 2.80915248 |
| 97 | bile acid and bile salt transport (GO:0015721) | 2.80634696 |
| 98 | glycine transport (GO:0015816) | 2.80439204 |
| 99 | glutamate secretion (GO:0014047) | 2.80267650 |
| 100 | regulation of protein activation cascade (GO:2000257) | 2.79470191 |
| 101 | glyoxylate metabolic process (GO:0046487) | 2.77235210 |
| 102 | vocalization behavior (GO:0071625) | 2.76930111 |
| 103 | detection of external biotic stimulus (GO:0098581) | 2.75792047 |
| 104 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.74832780 |
| 105 | protein-lipid complex remodeling (GO:0034368) | 2.74807880 |
| 106 | macromolecular complex remodeling (GO:0034367) | 2.74807880 |
| 107 | plasma lipoprotein particle remodeling (GO:0034369) | 2.74807880 |
| 108 | protein-lipid complex assembly (GO:0065005) | 2.72864081 |
| 109 | negative thymic T cell selection (GO:0045060) | 2.72294018 |
| 110 | complement activation, alternative pathway (GO:0006957) | 2.69712140 |
| 111 | regulation of mast cell degranulation (GO:0043304) | 2.69246054 |
| 112 | positive regulation of histone deacetylation (GO:0031065) | 2.67908269 |
| 113 | acylglycerol homeostasis (GO:0055090) | 2.67783960 |
| 114 | triglyceride homeostasis (GO:0070328) | 2.67783960 |
| 115 | protein localization to endosome (GO:0036010) | 2.66157695 |
| 116 | flavonoid metabolic process (GO:0009812) | 2.65964602 |
| 117 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.64439248 |
| 118 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.64214687 |
| 119 | germinal center formation (GO:0002467) | 2.64054869 |
| 120 | regulation of regulated secretory pathway (GO:1903305) | 2.63725613 |
| 121 | tyrosine metabolic process (GO:0006570) | 2.62579334 |
| 122 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.61091047 |
| 123 | regulation of complement activation (GO:0030449) | 2.60213461 |
| 124 | positive regulation of Rap GTPase activity (GO:0032854) | 2.59831062 |
| 125 | drug transmembrane transport (GO:0006855) | 2.59635139 |
| 126 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.58842786 |
| 127 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.58311648 |
| 128 | negative regulation of granulocyte differentiation (GO:0030853) | 2.57323213 |
| 129 | prepulse inhibition (GO:0060134) | 2.55762506 |
| 130 | B cell receptor signaling pathway (GO:0050853) | 2.55738884 |
| 131 | plasma lipoprotein particle clearance (GO:0034381) | 2.55735048 |
| 132 | positive regulation of lipid catabolic process (GO:0050996) | 2.55527567 |
| 133 | activation of Rac GTPase activity (GO:0032863) | 2.55306305 |
| 134 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.54932726 |
| 135 | regulation of fibrinolysis (GO:0051917) | 2.54058397 |
| 136 | response to pheromone (GO:0019236) | 2.53551255 |
| 137 | negative T cell selection (GO:0043383) | 2.52850609 |
| 138 | immunoglobulin mediated immune response (GO:0016064) | 2.52459824 |
| 139 | response to type I interferon (GO:0034340) | 2.51670359 |
| 140 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.50152910 |
| 141 | layer formation in cerebral cortex (GO:0021819) | 2.49917505 |
| 142 | type I interferon signaling pathway (GO:0060337) | 2.49706338 |
| 143 | cellular response to type I interferon (GO:0071357) | 2.49706338 |
| 144 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.49486980 |
| 145 | cholesterol homeostasis (GO:0042632) | 2.49128852 |
| 146 | sterol homeostasis (GO:0055092) | 2.48020389 |
| 147 | lipoprotein transport (GO:0042953) | 2.47692654 |
| 148 | alpha-amino acid catabolic process (GO:1901606) | 2.46858418 |
| 149 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.46675747 |
| 150 | amino-acid betaine metabolic process (GO:0006577) | 2.46101697 |
| 151 | coenzyme catabolic process (GO:0009109) | 2.45296350 |
| 152 | ethanol oxidation (GO:0006069) | 2.44995479 |
| 153 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.44991640 |
| 154 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.44857847 |
| 155 | phospholipid scrambling (GO:0017121) | 2.44706440 |
| 156 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.44704546 |
| 157 | nucleobase catabolic process (GO:0046113) | 2.44558079 |
| 158 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.44479319 |
| 159 | barbed-end actin filament capping (GO:0051016) | 2.44429829 |
| 160 | lipoprotein metabolic process (GO:0042157) | 2.44380395 |
| 161 | regulation of female receptivity (GO:0045924) | 2.44175679 |
| 162 | positive T cell selection (GO:0043368) | 2.43795379 |
| 163 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.43156688 |
| 164 | negative regulation of interleukin-12 production (GO:0032695) | 2.42795198 |
| 165 | aromatic amino acid family metabolic process (GO:0009072) | 2.42749302 |
| 166 | short-chain fatty acid metabolic process (GO:0046459) | 2.40596153 |
| 167 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.40559506 |
| 168 | detection of biotic stimulus (GO:0009595) | 2.39805630 |
| 169 | activation of JUN kinase activity (GO:0007257) | 2.39156150 |
| 170 | regulation of T cell tolerance induction (GO:0002664) | 2.37626534 |
| 171 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.36569849 |
| 172 | positive regulation of protein deacetylation (GO:0090312) | 2.34552789 |
| 173 | negative regulation of type 2 immune response (GO:0002829) | 2.34516986 |
| 174 | negative regulation of T cell mediated immunity (GO:0002710) | 2.32966982 |
| 175 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.32488685 |
| 176 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.31624682 |
| 177 | positive regulation of receptor recycling (GO:0001921) | 2.30012584 |
| 178 | regulation of early endosome to late endosome transport (GO:2000641) | 2.28987131 |
| 179 | cellular extravasation (GO:0045123) | 2.28771997 |
| 180 | semaphorin-plexin signaling pathway (GO:0071526) | 2.28743159 |
| 181 | regulation of defense response to virus by virus (GO:0050690) | 2.27978321 |
| 182 | positive regulation of B cell differentiation (GO:0045579) | 2.26366046 |
| 183 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.26066446 |
| 184 | regulation of antigen processing and presentation (GO:0002577) | 2.24985773 |
| 185 | regulation of necroptotic process (GO:0060544) | 2.24715441 |
| 186 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.23959973 |
| 187 | myeloid cell activation involved in immune response (GO:0002275) | 2.23718897 |
| 188 | positive regulation of antigen processing and presentation (GO:0002579) | 2.23363058 |
| 189 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.23284233 |
| 190 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.23083957 |
| 191 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.22938565 |
| 192 | response to host (GO:0075136) | 2.22938565 |
| 193 | response to host defenses (GO:0052200) | 2.22938565 |
| 194 | stress fiber assembly (GO:0043149) | 2.22239654 |
| 195 | apoptotic process involved in morphogenesis (GO:0060561) | 2.22104564 |
| 196 | detection of molecule of bacterial origin (GO:0032490) | 2.21591195 |
| 197 | negative regulation of innate immune response (GO:0045824) | 2.21559004 |
| 198 | modulation by symbiont of host cellular process (GO:0044068) | 2.20199840 |
| 199 | response to interleukin-15 (GO:0070672) | 2.19413112 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.62629247 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.39976244 |
| 3 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.04530483 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.92263324 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.85724323 |
| 6 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.57626062 |
| 7 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.51851023 |
| 8 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.46936909 |
| 9 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.46582486 |
| 10 | MYC_22102868_ChIP-Seq_BL_Human | 2.46206430 |
| 11 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.45409457 |
| 12 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.34814596 |
| 13 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.32084353 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.29286543 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.25310975 |
| 16 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.14299676 |
| 17 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.14078412 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.08381328 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.92610618 |
| 20 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.88682936 |
| 21 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.87417406 |
| 22 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.85096488 |
| 23 | MAF_26560356_Chip-Seq_TH1_Human | 1.83590629 |
| 24 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.82227380 |
| 25 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.77377384 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.67595765 |
| 27 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.67044242 |
| 28 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.65394730 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.64103600 |
| 30 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.63358585 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61084468 |
| 32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.60870638 |
| 33 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.60603481 |
| 34 | P68_20966046_ChIP-Seq_HELA_Human | 1.59815897 |
| 35 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.59644035 |
| 36 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.59087116 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.58811457 |
| 38 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.58250284 |
| 39 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.56475525 |
| 40 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.56446110 |
| 41 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.55832793 |
| 42 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.55516438 |
| 43 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.55340095 |
| 44 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.55340095 |
| 45 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.53349380 |
| 46 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.50474247 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.50100338 |
| 48 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.48774189 |
| 49 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47205429 |
| 50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.46127168 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45533724 |
| 52 | KDM2B_26808549_Chip-Seq_K562_Human | 1.45193237 |
| 53 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.44592933 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.42497771 |
| 55 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.42073825 |
| 56 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.41111322 |
| 57 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.41050028 |
| 58 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.40983486 |
| 59 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.40889657 |
| 60 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.39915265 |
| 61 | GATA1_22025678_ChIP-Seq_K562_Human | 1.37091875 |
| 62 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.36612014 |
| 63 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.35224530 |
| 64 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35089263 |
| 65 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.34922265 |
| 66 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.33973477 |
| 67 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.33351295 |
| 68 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32678179 |
| 69 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32557171 |
| 70 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.32172413 |
| 71 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.31854536 |
| 72 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30908091 |
| 73 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.30706762 |
| 74 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.30352623 |
| 75 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.29873144 |
| 76 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29754104 |
| 77 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.29525749 |
| 78 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29325500 |
| 79 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.29118886 |
| 80 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.28639278 |
| 81 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.27942880 |
| 82 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.27844185 |
| 83 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.27537556 |
| 84 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.27328833 |
| 85 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26787961 |
| 86 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.24822669 |
| 87 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.24600420 |
| 88 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.24184762 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.23022127 |
| 90 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.22611588 |
| 91 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.22279712 |
| 92 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.22275023 |
| 93 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.21495705 |
| 94 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.21444994 |
| 95 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21240481 |
| 96 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.19878731 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19421220 |
| 98 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.19154522 |
| 99 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19051436 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18374698 |
| 101 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.18301151 |
| 102 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.17724935 |
| 103 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17573601 |
| 104 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.17509812 |
| 105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17442896 |
| 106 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16166556 |
| 107 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.14955989 |
| 108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13843369 |
| 109 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.13275678 |
| 110 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.10869547 |
| 111 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10757262 |
| 112 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10612695 |
| 113 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.09810571 |
| 114 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.09285591 |
| 115 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.09168707 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08960799 |
| 117 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.08343917 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.08312791 |
| 119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08064765 |
| 120 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.05742365 |
| 121 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.05590690 |
| 122 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04997825 |
| 123 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.04446688 |
| 124 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.04155989 |
| 125 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.03781646 |
| 126 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.03057188 |
| 127 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.02297732 |
| 128 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00798296 |
| 129 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.00458527 |
| 130 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.00008469 |
| 131 | AR_19668381_ChIP-Seq_PC3_Human | 0.99583310 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99133380 |
| 133 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.99047485 |
| 134 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97917696 |
| 135 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.97847652 |
| 136 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97330304 |
| 137 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.96956660 |
| 138 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.96914732 |
| 139 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.96659609 |
| 140 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94812454 |
| 141 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.93063785 |
| 142 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.91944080 |
| 143 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90767404 |
| 144 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90426956 |
| 145 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.90254344 |
| 146 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89319762 |
| 147 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.88392466 |
| 148 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.88376876 |
| 149 | RXR_22108803_ChIP-Seq_LS180_Human | 0.88338562 |
| 150 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.85666369 |
| 151 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.84783697 |
| 152 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.84641403 |
| 153 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.84466015 |
| 154 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.83801598 |
| 155 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.82831939 |
| 156 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.82308079 |
| 157 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.81888398 |
| 158 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81475640 |
| 159 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.80637361 |
| 160 | GATA2_19941826_ChIP-Seq_K562_Human | 0.79315392 |
| 161 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.78573395 |
| 162 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.78492578 |
| 163 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.78457732 |
| 164 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.78422240 |
| 165 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.78133470 |
| 166 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.78019537 |
| 167 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.77835653 |
| 168 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.76739968 |
| 169 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.76504881 |
| 170 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.75410489 |
| 171 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.74846173 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 6.63952934 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 5.80361059 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.04143288 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.86798342 |
| 5 | MP0005365_abnormal_bile_salt | 3.81519340 |
| 6 | MP0003436_decreased_susceptibility_to | 3.49759415 |
| 7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.42501620 |
| 8 | MP0003252_abnormal_bile_duct | 3.06625533 |
| 9 | MP0003303_peritoneal_inflammation | 3.00153919 |
| 10 | MP0010329_abnormal_lipoprotein_level | 2.63255935 |
| 11 | MP0003724_increased_susceptibility_to | 2.52912198 |
| 12 | MP0009780_abnormal_chondrocyte_physiolo | 2.51321629 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.51154020 |
| 14 | MP0002822_catalepsy | 2.50342140 |
| 15 | MP0000569_abnormal_digit_pigmentation | 2.48301546 |
| 16 | MP0001835_abnormal_antigen_presentation | 2.44694446 |
| 17 | MP0009840_abnormal_foam_cell | 2.39714387 |
| 18 | MP0008260_abnormal_autophagy | 2.35818670 |
| 19 | MP0003635_abnormal_synaptic_transmissio | 2.16048574 |
| 20 | MP0002419_abnormal_innate_immunity | 2.07904735 |
| 21 | MP0010155_abnormal_intestine_physiology | 2.07135710 |
| 22 | MP0005083_abnormal_biliary_tract | 2.06817424 |
| 23 | MP0005025_abnormal_response_to | 2.06701389 |
| 24 | MP0010234_abnormal_vibrissa_follicle | 2.05317409 |
| 25 | MP0005409_darkened_coat_color | 1.97575104 |
| 26 | MP0003191_abnormal_cellular_cholesterol | 1.95383328 |
| 27 | MP0009046_muscle_twitch | 1.93943718 |
| 28 | MP0005387_immune_system_phenotype | 1.93430166 |
| 29 | MP0001790_abnormal_immune_system | 1.93430166 |
| 30 | MP0003329_amyloid_beta_deposits | 1.89347072 |
| 31 | MP0001849_ear_inflammation | 1.89074467 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.87609689 |
| 33 | MP0000685_abnormal_immune_system | 1.86531933 |
| 34 | MP0003763_abnormal_thymus_physiology | 1.86520202 |
| 35 | MP0003705_abnormal_hypodermis_morpholog | 1.82722590 |
| 36 | MP0001800_abnormal_humoral_immune | 1.82282828 |
| 37 | MP0006082_CNS_inflammation | 1.82102540 |
| 38 | MP0008961_abnormal_basal_metabolism | 1.80903616 |
| 39 | MP0005671_abnormal_response_to | 1.78695899 |
| 40 | MP0004270_analgesia | 1.73429602 |
| 41 | MP0001533_abnormal_skeleton_physiology | 1.72558705 |
| 42 | MP0000604_amyloidosis | 1.68986734 |
| 43 | MP0005332_abnormal_amino_acid | 1.67486172 |
| 44 | MP0001873_stomach_inflammation | 1.66530492 |
| 45 | MP0002064_seizures | 1.66306057 |
| 46 | MP0002723_abnormal_immune_serum | 1.66275472 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.65369702 |
| 48 | MP0001819_abnormal_immune_cell | 1.65035368 |
| 49 | MP0003880_abnormal_central_pattern | 1.63432175 |
| 50 | MP0002452_abnormal_antigen_presenting | 1.61654063 |
| 51 | MP0002118_abnormal_lipid_homeostasis | 1.60812136 |
| 52 | MP0009745_abnormal_behavioral_response | 1.59269256 |
| 53 | MP0009278_abnormal_bone_marrow | 1.58696234 |
| 54 | MP0002063_abnormal_learning/memory/cond | 1.56779174 |
| 55 | MP0003195_calcinosis | 1.51521490 |
| 56 | MP0003453_abnormal_keratinocyte_physiol | 1.51134480 |
| 57 | MP0009333_abnormal_splenocyte_physiolog | 1.50273181 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.50017468 |
| 59 | MP0002998_abnormal_bone_remodeling | 1.49920911 |
| 60 | MP0000858_altered_metastatic_potential | 1.47295670 |
| 61 | MP0004510_myositis | 1.46605917 |
| 62 | MP0004858_abnormal_nervous_system | 1.46306823 |
| 63 | MP0005464_abnormal_platelet_physiology | 1.45722539 |
| 64 | MP0009785_altered_susceptibility_to | 1.43964865 |
| 65 | MP0004381_abnormal_hair_follicle | 1.42767845 |
| 66 | MP0000609_abnormal_liver_physiology | 1.42555394 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.41919193 |
| 68 | MP0004019_abnormal_vitamin_homeostasis | 1.38804446 |
| 69 | MP0000678_abnormal_parathyroid_gland | 1.33751115 |
| 70 | MP0003566_abnormal_cell_adhesion | 1.33163945 |
| 71 | MP0003183_abnormal_peptide_metabolism | 1.30466500 |
| 72 | MP0003300_gastrointestinal_ulcer | 1.29698507 |
| 73 | MP0003279_aneurysm | 1.29339989 |
| 74 | MP0003172_abnormal_lysosome_physiology | 1.28498885 |
| 75 | MP0002572_abnormal_emotion/affect_behav | 1.28176527 |
| 76 | MP0003690_abnormal_glial_cell | 1.27936758 |
| 77 | MP0001486_abnormal_startle_reflex | 1.25292030 |
| 78 | MP0001845_abnormal_inflammatory_respons | 1.24690070 |
| 79 | MP0001440_abnormal_grooming_behavior | 1.24490639 |
| 80 | MP0002405_respiratory_system_inflammati | 1.24337440 |
| 81 | MP0002148_abnormal_hypersensitivity_rea | 1.23590871 |
| 82 | MP0003868_abnormal_feces_composition | 1.23275405 |
| 83 | MP0000716_abnormal_immune_system | 1.23122422 |
| 84 | MP0008004_abnormal_stomach_pH | 1.21537713 |
| 85 | MP0001958_emphysema | 1.20761679 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 1.19326508 |
| 87 | MP0002398_abnormal_bone_marrow | 1.17499478 |
| 88 | MP0002909_abnormal_adrenal_gland | 1.16954302 |
| 89 | MP0001348_abnormal_lacrimal_gland | 1.16354036 |
| 90 | MP0002933_joint_inflammation | 1.14729917 |
| 91 | MP0008569_lethality_at_weaning | 1.11458984 |
| 92 | MP0000490_abnormal_crypts_of | 1.10990903 |
| 93 | MP0001663_abnormal_digestive_system | 1.09871410 |
| 94 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09807586 |
| 95 | MP0008874_decreased_physiological_sensi | 1.09224527 |
| 96 | MP0005423_abnormal_somatic_nervous | 1.08660246 |
| 97 | MP0002254_reproductive_system_inflammat | 1.08234984 |
| 98 | MP0003879_abnormal_hair_cell | 1.07955951 |
| 99 | MP0005535_abnormal_body_temperature | 1.07530718 |
| 100 | MP0008872_abnormal_physiological_respon | 1.06656900 |
| 101 | MP0001851_eye_inflammation | 1.04525775 |
| 102 | MP0004185_abnormal_adipocyte_glucose | 1.04348737 |
| 103 | MP0008469_abnormal_protein_level | 1.03128056 |
| 104 | MP0003633_abnormal_nervous_system | 1.02559155 |
| 105 | MP0005666_abnormal_adipose_tissue | 1.02065722 |
| 106 | MP0002272_abnormal_nervous_system | 1.01744611 |
| 107 | MP0005310_abnormal_salivary_gland | 1.01151226 |
| 108 | MP0004043_abnormal_pH_regulation | 1.00253076 |
| 109 | MP0001968_abnormal_touch/_nociception | 1.00204108 |
| 110 | MP0003075_altered_response_to | 0.98035864 |
| 111 | MP0002396_abnormal_hematopoietic_system | 0.96882466 |
| 112 | MP0002429_abnormal_blood_cell | 0.96615950 |
| 113 | MP0004130_abnormal_muscle_cell | 0.96119823 |
| 114 | MP0002733_abnormal_thermal_nociception | 0.94851934 |
| 115 | MP0003828_pulmonary_edema | 0.94598161 |
| 116 | MP0000465_gastrointestinal_hemorrhage | 0.94004883 |
| 117 | MP0003045_fibrosis | 0.91528987 |
| 118 | MP0005448_abnormal_energy_balance | 0.91496785 |
| 119 | MP0005390_skeleton_phenotype | 0.91411621 |
| 120 | MP0002067_abnormal_sensory_capabilities | 0.91223352 |
| 121 | MP0005319_abnormal_enzyme/_coenzyme | 0.91187539 |
| 122 | MP0002722_abnormal_immune_system | 0.91020524 |
| 123 | MP0002734_abnormal_mechanical_nocicepti | 0.90756450 |
| 124 | MP0000703_abnormal_thymus_morphology | 0.90438035 |
| 125 | MP0005381_digestive/alimentary_phenotyp | 0.89523881 |
| 126 | MP0005386_behavior/neurological_phenoty | 0.89480493 |
| 127 | MP0004924_abnormal_behavior | 0.89480493 |
| 128 | MP0005023_abnormal_wound_healing | 0.89017084 |
| 129 | MP0003806_abnormal_nucleotide_metabolis | 0.88804551 |
| 130 | MP0005645_abnormal_hypothalamus_physiol | 0.88181849 |
| 131 | MP0002132_abnormal_respiratory_system | 0.87740961 |
| 132 | MP0002796_impaired_skin_barrier | 0.87211783 |
| 133 | MP0003283_abnormal_digestive_organ | 0.86571485 |
| 134 | MP0003631_nervous_system_phenotype | 0.85862245 |
| 135 | MP0004885_abnormal_endolymph | 0.84483811 |
| 136 | MP0004811_abnormal_neuron_physiology | 0.84215355 |
| 137 | MP0003632_abnormal_nervous_system | 0.84149906 |
| 138 | MP0001177_atelectasis | 0.82714977 |
| 139 | MP0002249_abnormal_larynx_morphology | 0.81789810 |
| 140 | MP0003448_altered_tumor_morphology | 0.80293258 |
| 141 | MP0005397_hematopoietic_system_phenotyp | 0.79263183 |
| 142 | MP0001545_abnormal_hematopoietic_system | 0.79263183 |
| 143 | MP0000689_abnormal_spleen_morphology | 0.78964517 |
| 144 | MP0005375_adipose_tissue_phenotype | 0.77316326 |
| 145 | MP0009643_abnormal_urine_homeostasis | 0.75123735 |
| 146 | MP0002069_abnormal_eating/drinking_beha | 0.75116074 |
| 147 | MP0000249_abnormal_blood_vessel | 0.73871556 |
| 148 | MP0002078_abnormal_glucose_homeostasis | 0.73744011 |
| 149 | MP0004883_abnormal_blood_vessel | 0.73548532 |
| 150 | MP0000955_abnormal_spinal_cord | 0.72820375 |
| 151 | MP0000538_abnormal_urinary_bladder | 0.72027355 |
| 152 | MP0002166_altered_tumor_susceptibility | 0.71436745 |
| 153 | MP0002557_abnormal_social/conspecific_i | 0.71281856 |
| 154 | MP0001765_abnormal_ion_homeostasis | 0.70409158 |
| 155 | MP0000015_abnormal_ear_pigmentation | 0.69721838 |
| 156 | MP0001970_abnormal_pain_threshold | 0.69651312 |
| 157 | MP0003795_abnormal_bone_structure | 0.69395477 |
| 158 | MP0005166_decreased_susceptibility_to | 0.69176584 |
| 159 | MP0002066_abnormal_motor_capabilities/c | 0.65841526 |
| 160 | MP0002735_abnormal_chemical_nociception | 0.65529641 |
| 161 | MP0009764_decreased_sensitivity_to | 0.65024797 |
| 162 | MP0004264_abnormal_extraembryonic_tissu | 0.64500889 |
| 163 | MP0002971_abnormal_brown_adipose | 0.64343953 |
| 164 | MP0002229_neurodegeneration | 0.63792963 |
| 165 | MP0004947_skin_inflammation | 0.62780587 |
| 166 | MP0005058_abnormal_lysosome_morphology | 0.62294417 |
| 167 | MP0002138_abnormal_hepatobiliary_system | 0.60403731 |
| 168 | MP0004142_abnormal_muscle_tone | 0.59738773 |
| 169 | MP0003866_abnormal_defecation | 0.59719149 |
| 170 | MP0002089_abnormal_postnatal_growth/wei | 0.59346786 |
| 171 | MP0003091_abnormal_cell_migration | 0.57126540 |
| 172 | MP0009765_abnormal_xenobiotic_induced | 0.56688631 |
| 173 | MP0002736_abnormal_nociception_after | 0.55834493 |
| 174 | MP0005451_abnormal_body_composition | 0.55585927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.71564774 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.20226965 |
| 3 | Xanthomatosis (HP:0000991) | 4.14142233 |
| 4 | Intrahepatic cholestasis (HP:0001406) | 4.09635310 |
| 5 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.66642978 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.62826222 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.56332185 |
| 8 | Abnormality of macrophages (HP:0004311) | 3.46018835 |
| 9 | Hypobetalipoproteinemia (HP:0003563) | 3.43500212 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.18598842 |
| 11 | Recurrent bacterial skin infections (HP:0005406) | 3.18150361 |
| 12 | Obstructive sleep apnea (HP:0002870) | 3.16627942 |
| 13 | Abnormality of the lower motor neuron (HP:0002366) | 3.03655107 |
| 14 | Focal seizures (HP:0007359) | 2.99701108 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 2.98767036 |
| 16 | Epidermoid cyst (HP:0200040) | 2.98065927 |
| 17 | Complement deficiency (HP:0004431) | 2.94152059 |
| 18 | Action tremor (HP:0002345) | 2.93487060 |
| 19 | Myokymia (HP:0002411) | 2.81553942 |
| 20 | Cellulitis (HP:0100658) | 2.78302427 |
| 21 | Broad face (HP:0000283) | 2.77508560 |
| 22 | Hypolipoproteinemia (HP:0010981) | 2.75028329 |
| 23 | Status epilepticus (HP:0002133) | 2.74846910 |
| 24 | Myositis (HP:0100614) | 2.73949268 |
| 25 | Increased IgE level (HP:0003212) | 2.73199170 |
| 26 | Cerebral aneurysm (HP:0004944) | 2.72708285 |
| 27 | Supranuclear gaze palsy (HP:0000605) | 2.72442513 |
| 28 | Ketosis (HP:0001946) | 2.71849623 |
| 29 | Gingivitis (HP:0000230) | 2.71800762 |
| 30 | Focal motor seizures (HP:0011153) | 2.71073247 |
| 31 | Hypercholesterolemia (HP:0003124) | 2.65266815 |
| 32 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.63326765 |
| 33 | Postural instability (HP:0002172) | 2.63091104 |
| 34 | Hyperammonemia (HP:0001987) | 2.62529454 |
| 35 | Visual hallucinations (HP:0002367) | 2.62322974 |
| 36 | Dysostosis multiplex (HP:0000943) | 2.59943518 |
| 37 | Hypoalphalipoproteinemia (HP:0003233) | 2.58012884 |
| 38 | Colitis (HP:0002583) | 2.57970092 |
| 39 | Hemorrhage of the eye (HP:0011885) | 2.57137057 |
| 40 | Abnormality of the common coagulation pathway (HP:0010990) | 2.56785423 |
| 41 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55535533 |
| 42 | Turricephaly (HP:0000262) | 2.52938238 |
| 43 | Prolonged partial thromboplastin time (HP:0003645) | 2.49851773 |
| 44 | Hemiplegia (HP:0002301) | 2.47312065 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.45823420 |
| 46 | Conjugated hyperbilirubinemia (HP:0002908) | 2.44143238 |
| 47 | Pustule (HP:0200039) | 2.43769086 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.42321728 |
| 49 | Thin bony cortex (HP:0002753) | 2.40390006 |
| 50 | Gastrointestinal inflammation (HP:0004386) | 2.38782519 |
| 51 | Orchitis (HP:0100796) | 2.37951904 |
| 52 | Abnormal social behavior (HP:0012433) | 2.36884994 |
| 53 | Impaired social interactions (HP:0000735) | 2.36884994 |
| 54 | Gastrointestinal infarctions (HP:0005244) | 2.36432693 |
| 55 | Hyperglycinuria (HP:0003108) | 2.36374288 |
| 56 | Obstructive lung disease (HP:0006536) | 2.34750124 |
| 57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.34750124 |
| 58 | Increased cerebral lipofuscin (HP:0011813) | 2.32451140 |
| 59 | Tetraplegia (HP:0002445) | 2.31297912 |
| 60 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.30203422 |
| 61 | Abnormality of glycine metabolism (HP:0010895) | 2.30203422 |
| 62 | Abnormality of proline metabolism (HP:0010907) | 2.29719450 |
| 63 | Hydroxyprolinuria (HP:0003080) | 2.29719450 |
| 64 | Recurrent fungal infections (HP:0002841) | 2.29517563 |
| 65 | Dysmetric saccades (HP:0000641) | 2.28663880 |
| 66 | Gout (HP:0001997) | 2.28201460 |
| 67 | Skin nodule (HP:0200036) | 2.26848688 |
| 68 | Cerebral inclusion bodies (HP:0100314) | 2.26606704 |
| 69 | Fat malabsorption (HP:0002630) | 2.26253933 |
| 70 | Inflammation of the large intestine (HP:0002037) | 2.25539622 |
| 71 | Abnormality of the nasal mucosa (HP:0000433) | 2.24733248 |
| 72 | Ketoacidosis (HP:0001993) | 2.23886965 |
| 73 | Sensorimotor neuropathy (HP:0007141) | 2.23348612 |
| 74 | Intention tremor (HP:0002080) | 2.22348510 |
| 75 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.22215158 |
| 76 | Cervical subluxation (HP:0003308) | 2.21295247 |
| 77 | Emphysema (HP:0002097) | 2.21158475 |
| 78 | Spontaneous hematomas (HP:0007420) | 2.19188035 |
| 79 | Meningitis (HP:0001287) | 2.18742649 |
| 80 | Flat acetabular roof (HP:0003180) | 2.17123998 |
| 81 | Acanthocytosis (HP:0001927) | 2.16706842 |
| 82 | Generalized tonic-clonic seizures (HP:0002069) | 2.15007166 |
| 83 | Mediastinal lymphadenopathy (HP:0100721) | 2.14730571 |
| 84 | Mitral stenosis (HP:0001718) | 2.14444224 |
| 85 | Nasal polyposis (HP:0100582) | 2.13108002 |
| 86 | Mucopolysacchariduria (HP:0008155) | 2.12118537 |
| 87 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12118537 |
| 88 | Recurrent skin infections (HP:0001581) | 2.10356226 |
| 89 | Hyperglycinemia (HP:0002154) | 2.10101758 |
| 90 | Systemic lupus erythematosus (HP:0002725) | 2.09483003 |
| 91 | Distal lower limb amyotrophy (HP:0008944) | 2.09339432 |
| 92 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.09237976 |
| 93 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.09237976 |
| 94 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.09237976 |
| 95 | Abnormality of purine metabolism (HP:0004352) | 2.08224162 |
| 96 | Stridor (HP:0010307) | 2.07731584 |
| 97 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.07450187 |
| 98 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.07426941 |
| 99 | Joint hemorrhage (HP:0005261) | 2.06884699 |
| 100 | Myocardial infarction (HP:0001658) | 2.06593004 |
| 101 | J-shaped sella turcica (HP:0002680) | 2.06007659 |
| 102 | Neurofibrillary tangles (HP:0002185) | 2.05812846 |
| 103 | Abnormality of glycolipid metabolism (HP:0010969) | 2.05802761 |
| 104 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.05802761 |
| 105 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.05802761 |
| 106 | Dysdiadochokinesis (HP:0002075) | 2.05771659 |
| 107 | Abnormality of the fingertips (HP:0001211) | 2.05380398 |
| 108 | Loss of speech (HP:0002371) | 2.04279641 |
| 109 | Neonatal onset (HP:0003623) | 2.02932010 |
| 110 | Abnormality of the Achilles tendon (HP:0005109) | 2.02835121 |
| 111 | Prolonged bleeding time (HP:0003010) | 2.02626273 |
| 112 | Absence seizures (HP:0002121) | 2.02243491 |
| 113 | Disproportionate tall stature (HP:0001519) | 2.00051731 |
| 114 | Bone pain (HP:0002653) | 1.99333431 |
| 115 | Abnormality of complement system (HP:0005339) | 1.98617359 |
| 116 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.97704136 |
| 117 | Papilledema (HP:0001085) | 1.97183480 |
| 118 | Polygenic inheritance (HP:0010982) | 1.95674467 |
| 119 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.95429196 |
| 120 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.95219949 |
| 121 | Premature loss of primary teeth (HP:0006323) | 1.95191901 |
| 122 | Macroorchidism (HP:0000053) | 1.95152240 |
| 123 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.94677414 |
| 124 | Malnutrition (HP:0004395) | 1.94657676 |
| 125 | Annular pancreas (HP:0001734) | 1.94152486 |
| 126 | Progressive cerebellar ataxia (HP:0002073) | 1.92755819 |
| 127 | Hypertriglyceridemia (HP:0002155) | 1.92708340 |
| 128 | Hyperacusis (HP:0010780) | 1.92289753 |
| 129 | Reticulocytosis (HP:0001923) | 1.92143046 |
| 130 | Torticollis (HP:0000473) | 1.91408216 |
| 131 | Scanning speech (HP:0002168) | 1.91403805 |
| 132 | Easy fatigability (HP:0003388) | 1.91393859 |
| 133 | Neuronal loss in central nervous system (HP:0002529) | 1.91221862 |
| 134 | Slow saccadic eye movements (HP:0000514) | 1.91103236 |
| 135 | Axonal loss (HP:0003447) | 1.90925546 |
| 136 | Confusion (HP:0001289) | 1.90646344 |
| 137 | Protrusio acetabuli (HP:0003179) | 1.90393512 |
| 138 | Dysmetria (HP:0001310) | 1.89607119 |
| 139 | Aneurysm (HP:0002617) | 1.89145141 |
| 140 | Abnormality of the intrinsic pathway (HP:0010989) | 1.88364854 |
| 141 | Amyloidosis (HP:0011034) | 1.87273054 |
| 142 | Increased connective tissue (HP:0009025) | 1.87238193 |
| 143 | Optic neuritis (HP:0100653) | 1.86273663 |
| 144 | Retrobulbar optic neuritis (HP:0100654) | 1.86273663 |
| 145 | Peritonitis (HP:0002586) | 1.84990438 |
| 146 | Ankle clonus (HP:0011448) | 1.84511796 |
| 147 | Spastic gait (HP:0002064) | 1.84271239 |
| 148 | Bradykinesia (HP:0002067) | 1.84017919 |
| 149 | Insomnia (HP:0100785) | 1.83859132 |
| 150 | Interstitial pulmonary disease (HP:0006530) | 1.83363660 |
| 151 | Global brain atrophy (HP:0002283) | 1.82838360 |
| 152 | Recurrent viral infections (HP:0004429) | 1.82532869 |
| 153 | Spastic tetraparesis (HP:0001285) | 1.82184947 |
| 154 | Hyperbilirubinemia (HP:0002904) | 1.82071218 |
| 155 | Vasculitis (HP:0002633) | 1.81339834 |
| 156 | Urinary urgency (HP:0000012) | 1.81284926 |
| 157 | Onion bulb formation (HP:0003383) | 1.79302368 |
| 158 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.77629009 |
| 159 | Recurrent cutaneous fungal infections (HP:0011370) | 1.77629009 |
| 160 | Long toe (HP:0010511) | 1.77603663 |
| 161 | Elfin facies (HP:0004428) | 1.76746733 |
| 162 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.76668001 |
| 163 | Mitral regurgitation (HP:0001653) | 1.75890919 |
| 164 | Abnormality of nucleobase metabolism (HP:0010932) | 1.75868342 |
| 165 | Gastrointestinal stroma tumor (HP:0100723) | 1.75840027 |
| 166 | Chronic otitis media (HP:0000389) | 1.75570737 |
| 167 | Cholelithiasis (HP:0001081) | 1.75326285 |
| 168 | Atonic seizures (HP:0010819) | 1.74771182 |
| 169 | Depression (HP:0000716) | 1.74587568 |
| 170 | Poor eye contact (HP:0000817) | 1.74151800 |
| 171 | Dilatation of the ascending aorta (HP:0005111) | 1.73263754 |
| 172 | Resting tremor (HP:0002322) | 1.73206917 |
| 173 | Abnormal eating behavior (HP:0100738) | 1.73154482 |
| 174 | Hypophosphatemia (HP:0002148) | 1.73103577 |
| 175 | Widely patent fontanelles and sutures (HP:0004492) | 1.72462663 |
| 176 | Abnormality of the thoracic spine (HP:0100711) | 1.72388020 |
| 177 | Spastic diplegia (HP:0001264) | 1.72342848 |
| 178 | Encephalitis (HP:0002383) | 1.72066572 |
| 179 | Dialeptic seizures (HP:0011146) | 1.71677132 |
| 180 | Postural tremor (HP:0002174) | 1.71528603 |
| 181 | Gastrointestinal dysmotility (HP:0002579) | 1.71412621 |
| 182 | Upper limb amyotrophy (HP:0009129) | 1.71300233 |
| 183 | Distal upper limb amyotrophy (HP:0007149) | 1.71300233 |
| 184 | Fragile skin (HP:0001030) | 1.70297065 |
| 185 | Osteomyelitis (HP:0002754) | 1.69086982 |
| 186 | Purpura (HP:0000979) | 1.68885800 |
| 187 | Metaphyseal cupping (HP:0003021) | 1.68751606 |
| 188 | Atrophic scars (HP:0001075) | 1.67513166 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.47029458 |
| 2 | MAP3K9 | 3.40962396 |
| 3 | NTRK3 | 2.84061287 |
| 4 | MAP4K1 | 2.74609788 |
| 5 | EPHA4 | 2.59645600 |
| 6 | DAPK2 | 2.27543056 |
| 7 | SMG1 | 2.11483285 |
| 8 | RIPK1 | 1.92761249 |
| 9 | MAP2K4 | 1.91078527 |
| 10 | KSR2 | 1.90645873 |
| 11 | MAP2K3 | 1.88933802 |
| 12 | MAP3K4 | 1.87199750 |
| 13 | MAP3K13 | 1.85722925 |
| 14 | SIK1 | 1.84887854 |
| 15 | SIK2 | 1.82938202 |
| 16 | MST1R | 1.81625246 |
| 17 | NTRK2 | 1.77988570 |
| 18 | FGFR4 | 1.72634832 |
| 19 | TNK2 | 1.72005473 |
| 20 | PTK6 | 1.64064118 |
| 21 | ERN1 | 1.63576575 |
| 22 | MAP3K11 | 1.61408892 |
| 23 | IRAK3 | 1.58342349 |
| 24 | CAMKK1 | 1.57603325 |
| 25 | NTRK1 | 1.56844906 |
| 26 | MARK1 | 1.55955398 |
| 27 | RIPK4 | 1.54084223 |
| 28 | BLK | 1.52150347 |
| 29 | ZAP70 | 1.51666988 |
| 30 | PAK6 | 1.51571209 |
| 31 | STK38 | 1.51104537 |
| 32 | CAMK1G | 1.49786839 |
| 33 | EPHA2 | 1.48304317 |
| 34 | EEF2K | 1.46436114 |
| 35 | MAP3K2 | 1.46371936 |
| 36 | IRAK4 | 1.45336617 |
| 37 | CSK | 1.43027757 |
| 38 | CAMK1D | 1.42684631 |
| 39 | PRKD2 | 1.41810621 |
| 40 | TRIB3 | 1.40940576 |
| 41 | MAP3K10 | 1.35873855 |
| 42 | LMTK2 | 1.34848880 |
| 43 | INSRR | 1.31845072 |
| 44 | SGK3 | 1.29773352 |
| 45 | MINK1 | 1.28033597 |
| 46 | TYRO3 | 1.27186989 |
| 47 | RET | 1.23183868 |
| 48 | PRKCH | 1.19797841 |
| 49 | MAP3K7 | 1.18660030 |
| 50 | MAP3K3 | 1.18174494 |
| 51 | TAOK1 | 1.14683122 |
| 52 | GRK6 | 1.14468772 |
| 53 | JAK1 | 1.13798993 |
| 54 | BTK | 1.12587271 |
| 55 | WNK1 | 1.09632297 |
| 56 | PKN2 | 1.07675453 |
| 57 | SCYL2 | 1.06564698 |
| 58 | PDPK1 | 1.03749885 |
| 59 | PDGFRA | 1.03705589 |
| 60 | FRK | 1.02928554 |
| 61 | BMX | 1.02111110 |
| 62 | CDK5 | 1.00514796 |
| 63 | MAP3K14 | 1.00474119 |
| 64 | PTK2 | 0.99704433 |
| 65 | JAK3 | 0.99564480 |
| 66 | TAOK2 | 0.98748952 |
| 67 | TAOK3 | 0.98142581 |
| 68 | FGFR2 | 0.94665378 |
| 69 | SIK3 | 0.93353234 |
| 70 | ALK | 0.92346153 |
| 71 | EPHB1 | 0.91818661 |
| 72 | PAK4 | 0.91406540 |
| 73 | HCK | 0.90697369 |
| 74 | PDK1 | 0.89860451 |
| 75 | MAP3K6 | 0.88138839 |
| 76 | MAPK12 | 0.85339846 |
| 77 | SGK223 | 0.84459296 |
| 78 | SGK494 | 0.84459296 |
| 79 | SGK2 | 0.84037419 |
| 80 | KSR1 | 0.81730847 |
| 81 | IRAK2 | 0.81203716 |
| 82 | JAK2 | 0.80396125 |
| 83 | CDC42BPA | 0.79468748 |
| 84 | CSF1R | 0.76572861 |
| 85 | ICK | 0.76503907 |
| 86 | BCKDK | 0.75074295 |
| 87 | STK11 | 0.74011658 |
| 88 | CDK12 | 0.73985808 |
| 89 | FGR | 0.72833006 |
| 90 | FER | 0.72628518 |
| 91 | ERBB2 | 0.72329842 |
| 92 | FES | 0.71312905 |
| 93 | MAP3K1 | 0.69887059 |
| 94 | HIPK2 | 0.69576922 |
| 95 | TGFBR2 | 0.69231802 |
| 96 | IKBKE | 0.69119890 |
| 97 | TBK1 | 0.68930392 |
| 98 | SYK | 0.68895213 |
| 99 | PRKD3 | 0.68778698 |
| 100 | RPS6KL1 | 0.67851239 |
| 101 | RPS6KC1 | 0.67851239 |
| 102 | ITK | 0.66433167 |
| 103 | SGK1 | 0.66190547 |
| 104 | ERBB4 | 0.65088190 |
| 105 | CAMKK2 | 0.64809094 |
| 106 | DYRK1B | 0.64303009 |
| 107 | PHKG1 | 0.63233661 |
| 108 | PHKG2 | 0.63233661 |
| 109 | LRRK2 | 0.62305042 |
| 110 | PRKCG | 0.61993325 |
| 111 | LCK | 0.61862746 |
| 112 | PRKCZ | 0.61536693 |
| 113 | PAK3 | 0.61235484 |
| 114 | PRKAA1 | 0.59362612 |
| 115 | MARK2 | 0.58785241 |
| 116 | MAP2K6 | 0.57545599 |
| 117 | DDR2 | 0.57105727 |
| 118 | TESK2 | 0.56041202 |
| 119 | TYK2 | 0.55280541 |
| 120 | ARAF | 0.54889357 |
| 121 | FGFR3 | 0.54756550 |
| 122 | RPS6KA3 | 0.54702985 |
| 123 | MAPK11 | 0.54549350 |
| 124 | CAMK4 | 0.54195761 |
| 125 | MET | 0.53652509 |
| 126 | TESK1 | 0.53078202 |
| 127 | MAPK7 | 0.52686275 |
| 128 | MAP2K1 | 0.52649912 |
| 129 | PRKAA2 | 0.52013447 |
| 130 | MTOR | 0.51579737 |
| 131 | GRK5 | 0.51563480 |
| 132 | FYN | 0.51333222 |
| 133 | TTN | 0.51227249 |
| 134 | MAP2K2 | 0.51143932 |
| 135 | DAPK1 | 0.50121276 |
| 136 | RPS6KA2 | 0.49503215 |
| 137 | CAMK1 | 0.49462439 |
| 138 | RPS6KA6 | 0.48517348 |
| 139 | PDGFRB | 0.48475779 |
| 140 | PRKACG | 0.48343713 |
| 141 | LYN | 0.46466470 |
| 142 | PRKG2 | 0.45603329 |
| 143 | LATS2 | 0.45446897 |
| 144 | PTK2B | 0.43885674 |
| 145 | CAMK2G | 0.42011725 |
| 146 | MAPK15 | 0.38842017 |
| 147 | MOS | 0.38148161 |
| 148 | NME2 | 0.37743306 |
| 149 | MAP3K8 | 0.34647385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.74208271 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.78693368 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.75404034 |
| 4 | Other glycan degradation_Homo sapiens_hsa00511 | 2.55018470 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.53441971 |
| 6 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.28393230 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.18441457 |
| 8 | Bile secretion_Homo sapiens_hsa04976 | 2.18250924 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.01067180 |
| 10 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.94984470 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.83518166 |
| 12 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.82191709 |
| 13 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81647754 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.74512492 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.64790108 |
| 16 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.60708923 |
| 17 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.60320520 |
| 18 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.57973822 |
| 19 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.55209978 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.51656724 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.45024425 |
| 22 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.44983583 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.44593108 |
| 24 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44130193 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42861712 |
| 26 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.36225066 |
| 27 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.32379389 |
| 28 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.30814211 |
| 29 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.30495621 |
| 30 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30404589 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.29107702 |
| 32 | Tuberculosis_Homo sapiens_hsa05152 | 1.28984266 |
| 33 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27983664 |
| 34 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.27150282 |
| 35 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.26596262 |
| 36 | Nicotine addiction_Homo sapiens_hsa05033 | 1.26212521 |
| 37 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.24732371 |
| 38 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.24300426 |
| 39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.23496743 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22394108 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.21311880 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.18520388 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.18440850 |
| 44 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.16867705 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.16746544 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.16438043 |
| 47 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.14754069 |
| 48 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.13975419 |
| 49 | Lysine degradation_Homo sapiens_hsa00310 | 1.13741406 |
| 50 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.13246723 |
| 51 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.13045631 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.11855775 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 1.09467689 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 1.08751682 |
| 55 | Histidine metabolism_Homo sapiens_hsa00340 | 1.06619285 |
| 56 | Endometrial cancer_Homo sapiens_hsa05213 | 1.05293087 |
| 57 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.04384366 |
| 58 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.02917758 |
| 59 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.02913109 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.02554862 |
| 61 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02397518 |
| 62 | Allograft rejection_Homo sapiens_hsa05330 | 1.01515903 |
| 63 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.00820993 |
| 64 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.99175696 |
| 65 | Influenza A_Homo sapiens_hsa05164 | 0.98910688 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98717748 |
| 67 | Salivary secretion_Homo sapiens_hsa04970 | 0.98559408 |
| 68 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.96486257 |
| 69 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.96435443 |
| 70 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.95423024 |
| 71 | Endocytosis_Homo sapiens_hsa04144 | 0.93413707 |
| 72 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.93390601 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.93274654 |
| 74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.93234543 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.93213430 |
| 76 | Platelet activation_Homo sapiens_hsa04611 | 0.92340307 |
| 77 | Lysosome_Homo sapiens_hsa04142 | 0.92281766 |
| 78 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.92223164 |
| 79 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.91529741 |
| 80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.91506586 |
| 81 | Insulin secretion_Homo sapiens_hsa04911 | 0.91366169 |
| 82 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.91346861 |
| 83 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91246944 |
| 84 | Long-term potentiation_Homo sapiens_hsa04720 | 0.89686050 |
| 85 | Peroxisome_Homo sapiens_hsa04146 | 0.89259753 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.88949688 |
| 87 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.88341547 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.88338690 |
| 89 | Circadian entrainment_Homo sapiens_hsa04713 | 0.88204183 |
| 90 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.87914963 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.87897114 |
| 92 | * Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.87599245 |
| 93 | Mineral absorption_Homo sapiens_hsa04978 | 0.85967844 |
| 94 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.85765423 |
| 95 | Salmonella infection_Homo sapiens_hsa05132 | 0.85517708 |
| 96 | Pertussis_Homo sapiens_hsa05133 | 0.85000501 |
| 97 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.84776498 |
| 98 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.84227947 |
| 99 | Malaria_Homo sapiens_hsa05144 | 0.83923489 |
| 100 | Cocaine addiction_Homo sapiens_hsa05030 | 0.82813859 |
| 101 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.82700464 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82628228 |
| 103 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.81907029 |
| 104 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81759311 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.81639802 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.80592833 |
| 107 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.80340089 |
| 108 | Measles_Homo sapiens_hsa05162 | 0.80165729 |
| 109 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77317095 |
| 110 | * Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.75639031 |
| 111 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.75577210 |
| 112 | Apoptosis_Homo sapiens_hsa04210 | 0.75416327 |
| 113 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.75213399 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.73885821 |
| 115 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.73028000 |
| 116 | Morphine addiction_Homo sapiens_hsa05032 | 0.71500657 |
| 117 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.70947589 |
| 118 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.70546681 |
| 119 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.69843810 |
| 120 | Shigellosis_Homo sapiens_hsa05131 | 0.69643490 |
| 121 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69641333 |
| 122 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.69184061 |
| 123 | Phagosome_Homo sapiens_hsa04145 | 0.68866470 |
| 124 | Olfactory transduction_Homo sapiens_hsa04740 | 0.68528263 |
| 125 | Bladder cancer_Homo sapiens_hsa05219 | 0.68392054 |
| 126 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.67979151 |
| 127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.67292225 |
| 128 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.66982342 |
| 129 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.66753899 |
| 130 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.66317601 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.66297142 |
| 132 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.66174826 |
| 133 | Focal adhesion_Homo sapiens_hsa04510 | 0.66155465 |
| 134 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.65737503 |
| 135 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.65065053 |
| 136 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.64452146 |
| 137 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.64391283 |
| 138 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.64273342 |
| 139 | Colorectal cancer_Homo sapiens_hsa05210 | 0.64218706 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.63594276 |
| 141 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.62090711 |
| 142 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61923374 |
| 143 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60954634 |
| 144 | * Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.60367708 |
| 145 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.60019037 |
| 146 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59980002 |
| 147 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.59579531 |
| 148 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.59455749 |
| 149 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.58843971 |
| 150 | Renin secretion_Homo sapiens_hsa04924 | 0.58494868 |
| 151 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.58356947 |
| 152 | Long-term depression_Homo sapiens_hsa04730 | 0.58259581 |
| 153 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.57851757 |
| 154 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.57177921 |
| 155 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57132499 |
| 156 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.56234046 |
| 157 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.56189831 |
| 158 | Retinol metabolism_Homo sapiens_hsa00830 | 0.55796304 |
| 159 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54868043 |
| 160 | Thyroid cancer_Homo sapiens_hsa05216 | 0.53846861 |
| 161 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.53461712 |
| 162 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52498214 |
| 163 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51960855 |
| 164 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.51724357 |
| 165 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.51559715 |
| 166 | Galactose metabolism_Homo sapiens_hsa00052 | 0.50018137 |
| 167 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.49965589 |
| 168 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49702507 |
| 169 | Taste transduction_Homo sapiens_hsa04742 | 0.47303879 |
| 170 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.46152765 |
| 171 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.45928488 |
| 172 | * Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.45907301 |
| 173 | * Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43931722 |
| 174 | Carbon metabolism_Homo sapiens_hsa01200 | 0.43455052 |
| 175 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.42933119 |
| 176 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42870806 |
| 177 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.41997314 |
| 178 | Glioma_Homo sapiens_hsa05214 | 0.40440173 |
| 179 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.39961345 |
| 180 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39107237 |

